cancer drugs

Gilead to Buy Forty Seven for $4.9B
Merck, Sanofi in Deals for Cancer Drug Firms
Bristol-Myers to Buy Big Pharma Rival Celgene
Glaxo Makes $5.1B Move Into Cancer Drugs
J&J Gets Boost From Strong Cancer Drug Sales
Roche Takes Full Control of Genomic Profiler
Takeda Buys Ariad in $5.2B Cancer Drug Bet